Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Personalized Cancer Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Personalized Cancer Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Personalized Cancer Medicine Overall Market Size
2.1 Global Personalized Cancer Medicine Market Size: 2021 VS 2028
2.2 Global Personalized Cancer Medicine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Personalized Cancer Medicine Players in Global Market
3.2 Top Global Personalized Cancer Medicine Companies Ranked by Revenue
3.3 Global Personalized Cancer Medicine Revenue by Companies
3.4 Top 3 and Top 5 Personalized Cancer Medicine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Personalized Cancer Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Personalized Cancer Medicine Players in Global Market
3.6.1 List of Global Tier 1 Personalized Cancer Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Personalized Cancer Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Personalized Cancer Medicine Market Size Markets, 2021 & 2028
4.1.2 Monoclonal Antibodies
4.1.3 Personalized Cancer Vaccines
4.1.4 Other
4.2 By Type - Global Personalized Cancer Medicine Revenue & Forecasts
4.2.1 By Type - Global Personalized Cancer Medicine Revenue, 2017-2022
4.2.2 By Type - Global Personalized Cancer Medicine Revenue, 2023-2028
4.2.3 By Type - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Personalized Cancer Medicine Market Size, 2021 & 2028
5.1.2 Breast Cancer
5.1.3 Lung Cancer
5.1.4 Chronic Myeloid Leukaemia
5.1.5 Bowel Cancer
5.1.6 Other Cancer
5.2 By Application - Global Personalized Cancer Medicine Revenue & Forecasts
5.2.1 By Application - Global Personalized Cancer Medicine Revenue, 2017-2022
5.2.2 By Application - Global Personalized Cancer Medicine Revenue, 2023-2028
5.2.3 By Application - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Personalized Cancer Medicine Market Size, 2021 & 2028
6.2 By Region - Global Personalized Cancer Medicine Revenue & Forecasts
6.2.1 By Region - Global Personalized Cancer Medicine Revenue, 2017-2022
6.2.2 By Region - Global Personalized Cancer Medicine Revenue, 2023-2028
6.2.3 By Region - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Personalized Cancer Medicine Revenue, 2017-2028
6.3.2 US Personalized Cancer Medicine Market Size, 2017-2028
6.3.3 Canada Personalized Cancer Medicine Market Size, 2017-2028
6.3.4 Mexico Personalized Cancer Medicine Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Personalized Cancer Medicine Revenue, 2017-2028
6.4.2 Germany Personalized Cancer Medicine Market Size, 2017-2028
6.4.3 France Personalized Cancer Medicine Market Size, 2017-2028
6.4.4 U.K. Personalized Cancer Medicine Market Size, 2017-2028
6.4.5 Italy Personalized Cancer Medicine Market Size, 2017-2028
6.4.6 Russia Personalized Cancer Medicine Market Size, 2017-2028
6.4.7 Nordic Countries Personalized Cancer Medicine Market Size, 2017-2028
6.4.8 Benelux Personalized Cancer Medicine Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Personalized Cancer Medicine Revenue, 2017-2028
6.5.2 China Personalized Cancer Medicine Market Size, 2017-2028
6.5.3 Japan Personalized Cancer Medicine Market Size, 2017-2028
6.5.4 South Korea Personalized Cancer Medicine Market Size, 2017-2028
6.5.5 Southeast Asia Personalized Cancer Medicine Market Size, 2017-2028
6.5.6 India Personalized Cancer Medicine Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Personalized Cancer Medicine Revenue, 2017-2028
6.6.2 Brazil Personalized Cancer Medicine Market Size, 2017-2028
6.6.3 Argentina Personalized Cancer Medicine Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Personalized Cancer Medicine Revenue, 2017-2028
6.7.2 Turkey Personalized Cancer Medicine Market Size, 2017-2028
6.7.3 Israel Personalized Cancer Medicine Market Size, 2017-2028
6.7.4 Saudi Arabia Personalized Cancer Medicine Market Size, 2017-2028
6.7.5 UAE Personalized Cancer Medicine Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Personalized Cancer Medicine Major Product Offerings
7.1.4 Abbott Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Personalized Cancer Medicine Major Product Offerings
7.2.4 Merck Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.2.5 Merck Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Personalized Cancer Medicine Major Product Offerings
7.3.4 Novartis Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.3.5 Novartis Key News
7.4 Amgen
7.4.1 Amgen Corporate Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Personalized Cancer Medicine Major Product Offerings
7.4.4 Amgen Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.4.5 Amgen Key News
7.5 Celgene
7.5.1 Celgene Corporate Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Personalized Cancer Medicine Major Product Offerings
7.5.4 Celgene Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.5.5 Celgene Key News
7.6 Bayer
7.6.1 Bayer Corporate Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Personalized Cancer Medicine Major Product Offerings
7.6.4 Bayer Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.6.5 Bayer Key News
7.7 Roche
7.7.1 Roche Corporate Summary
7.7.2 Roche Business Overview
7.7.3 Roche Personalized Cancer Medicine Major Product Offerings
7.7.4 Roche Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.7.5 Roche Key News
7.8 Astellas
7.8.1 Astellas Corporate Summary
7.8.2 Astellas Business Overview
7.8.3 Astellas Personalized Cancer Medicine Major Product Offerings
7.8.4 Astellas Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.8.5 Astellas Key News
7.9 Astrazeneca
7.9.1 Astrazeneca Corporate Summary
7.9.2 Astrazeneca Business Overview
7.9.3 Astrazeneca Personalized Cancer Medicine Major Product Offerings
7.9.4 Astrazeneca Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.9.5 Astrazeneca Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Personalized Cancer Medicine Major Product Offerings
7.10.4 Johnson & Johnson Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.10.5 Johnson & Johnson Key News
7.11 Agilent
7.11.1 Agilent Corporate Summary
7.11.2 Agilent Business Overview
7.11.3 Agilent Personalized Cancer Medicine Major Product Offerings
7.11.4 Agilent Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.11.5 Agilent Key News
7.12 Takeda
7.12.1 Takeda Corporate Summary
7.12.2 Takeda Business Overview
7.12.3 Takeda Personalized Cancer Medicine Major Product Offerings
7.12.4 Takeda Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.12.5 Takeda Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer